From Medscape Diabetes & Endocrinology

Medscape Medical News from

ENDO 2015: The Endocrine Society Annual Meeting

March 05 - 08, 2015; San Diego, California

Conference News

ENDO More Studies Support Testosterone CV Safety, Debate Continues
Medscape Medical News, March 16, 2015
ENDO Intranasal Oxytocin Cuts Calorie Consumption in Healthy Men
Medscape Medical News, March 9, 2015
ENDO Trained Dogs Sniff Out Thyroid Cancer With High Accuracy
Medscape Medical News, March 9, 2015
ENDO Breast Cancer Survivors at Increased Risk for Thyroid Cancer
Medscape Medical News, March 8, 2015
ENDO 50 Shades of Gray: Depression Common in Borderline Testosterone
Medscape Medical News, March 7, 2015

ENDO No Link Seen Between Hormone Replacement Therapy, Mortality
Medscape Medical News, March 7, 2015
ENDO Endocrine Disruptors Cause Range of Diseases; Cost 157 Billion Euros
Medscape Medical News, March 6, 2015
ENDO Novel Agent Abaloparatide Reduces Fractures, Including Wrist
Medscape Medical News, March 6, 2015
ENDO Menopause, Obesity, and Diabetes Top ENDO 2015 Agenda
Medscape Medical News, February 27, 2015

Medscape Diabetes© WebMD, LLC

Expert Commentaries

CV Safety of Diabetes Drugs: What Do We Know?
Silvio E. Inzucchi, MD
Which Women Are the Best Candidates for HRT?
JoAnn E. Manson, MD, DrPH
Pearls for Primary Care From ENDO 2015
Matthew L. Mintz, MD

Live Blog

News and Views from ENDO 2015 Coverage of key advances and expert reactions as they happened at the meeting.

Previous Coverage